Merck bags imperfect immunotherapy first with Keytruda cervical cancer approval

Merck & Co. is adding yet another immuno-oncology first under Keytruda’s belt. But the breadth of the win comes out less than ideal. The FDA has backed Keytruda’s use alongside chemotherapy, with or without Roche’s Avastin, for treating patients with persistent, recurrent or metastatic cervical cancer but only for those whose tumors express the PD-L1… Read More »

Support for Drug Price Negotiation Brings Partisans Together in the U.S.

Most U.S. adults across political parties favor allowing the Federal government authority to negotiate for drug prices — even after hearing the arguments against the health policy. Drug price negotiation, say by the Medicare program, is a unifying public policy in the current era of political schisms in America, based on the findings in a… Read More »

How to live longer: High doses of this vitamin may ‘raise risk’ of cancer recurrence

Though our life expectancy may seem out of our control, everyday life decisions can aid longevity and help us live happier, longer lives. While certain foods could boost longevity, simply lowering intake of meat-based protein could also be linked to a longer lifespan. For example, many studies link a plant-rich diet to a lower risk… Read More »

Plant-based food companies face critics: environmental advocates

But some are not so sure. One investor-tracking firm gives Beyond Meat a zero when it comes to sustainability measures. Another rates it a “severe risk,” putting it on a par with beef and chicken processing giants JBS and Tyson. “We don’t feel we have sufficient information to say Beyond Meat is fundamentally different from… Read More »